Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.24.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 11,523 $ 32,190
Marketable securities, current   28,859
Prepaid expenses 2,195 3,459
Grants revenue receivable 250  
Other current assets 2,804 3,790
Total current assets 16,772 68,298
Operating lease right-of-use assets 9,161 11,132
Property and equipment, net 7,393 14,632
Other assets 2,057 3,486
Total assets 35,383 97,548
Current liabilities:    
Accounts payable 1,523 504
Accrued liabilities 4,279 8,823
Deferred revenue, current 9,031 45,573
Other current liabilities 2,488 2,182
Total current liabilities 17,321 57,082
Deferred revenue, long-term   5,904
Long-term debt, net of current portion   36,168
Operating lease liabilities, long term portion 9,742 12,231
Contingent value right liability 2,702  
Other liabilities 1,406 1,295
Total liabilities 31,171 112,680
Commitments and contingencies (Note 10)
Stockholders' equity/(deficit)    
Preferred stock, $0.001 par value per share: Authorized: 2,000,000 shares as of December 31, 2023 and 2022; Issued and outstanding: 250 shares as of December 31, 2023 and 2022
Common stock, $0.001 par value per share: Authorized: 150,000,000 shares as of December 31, 2023 and 2022; Issued and outstanding: 5,374,268 shares as of December 31, 2023 and 3,756,711 shares as of December 31, 2022 [1] 5 4
Additional paid-in capital [1] 457,099 429,698
Accumulated other comprehensive loss   (66)
Accumulated deficit (452,892) (444,768)
Total stockholders' equity/(deficit) 4,212 (15,132)
Total liabilities and stockholders' equity/(deficit) $ 35,383 $ 97,548
[1] Prior period amounts have been retrospectively adjusted for the 1-for-15 reverse stock split that was effective August 11, 2023 (see Note 1).